Effect of spinal manipulation on sensorimotor functions in back pain patients: study protocol for a randomised controlled trial by Wilder, David G et al.
STUDY PROTOCOL Open Access
Effect of spinal manipulation on sensorimotor
functions in back pain patients: study protocol
for a randomised controlled trial
David G Wilder
1, Robert D Vining
2, Katherine A Pohlman
2, William C Meeker
3, Ting Xia
2, James W DeVocht
2,
R Maruti Gudavalli
2, Cynthia R Long
2, Edward F Owens
4 and Christine M Goertz
2*
Abstract
Background: Low back pain (LBP) is a recognized public health problem, impacting up to 80% of US adults at some
point in their lives. Patients with LBP are utilizing integrative health care such as spinal manipulation (SM). SM is the
therapeutic application of a load to specific body tissues or structures and can be divided into two broad categories:
SM with a high-velocity low-amplitude load, or an impulse “thrust”, (HVLA-SM) and SM with a low-velocity variable-
amplitude load (LVVA-SM). There is evidence that sensorimotor function in people with LBP is altered. This study
evaluates the sensorimotor function in the lumbopelvic region, as measured by postural sway, response to sudden load
and repositioning accuracy, following SM to the lumbar and pelvic region when compared to a sham treatment.
Methods/Design: A total of 219 participants with acute, subacute or chronic low back pain are being recruited from
the Quad Cities area located in Iowa and Illinois. They are allocated through a minimization algorithm in a 1:1:1 ratio to
receive either 13 HVLA-SM treatments over 6 weeks, 13 LVVA-SM treatments over 6 weeks or 2 weeks of a sham
treatment followed by 4 weeks of full spine “doctor’sc h o i c e ” SM. Sensorimotor function tests are performed before and
immediately after treatment at baseline, week 2 and week 6. Self-report outcome assessments are also collected. The
primary aims of this study are to 1) determine immediate pre to post changes in sensorimotor function as measured by
postural sway following delivery of a single HVLA-SM or LVVA-SM treatment when compared to a sham treatment and
2) to determine changes from baseline to 2 weeks (4 treatments) of HVLA-SM or LVVA-SM compared to a sham
treatment. Secondary aims include changes in response to sudden loads and lumbar repositioning accuracy at these
endpoints, estimating sensorimotor function in the SM groups after 6 weeks of treatment, and exploring if changes in
sensorimotor function are associated with changes in self-report outcome assessments.
Discussion: This study may provide clues to the sensorimotor mechanisms that explain observed functional
deficits associated with LBP, as well as the mechanism of action of SM.
Trial registration: This trial is registered in ClinicalTrials.gov, with the ID number of NCT00830596, registered on
January 27, 2009. The first participant was allocated on 30 January 2009 and the final participant was allocated on
17 March 2011.
Background
Low back pain (LBP) is well recognized as a public
health problem, impacting up to 80% of US adults at
some point in their lives [1]. Estimates of the point pre-
valence vary from 12-33% and lifetime prevalence vary
from 11-84% [2]. The pathophysiology of patients with
LBP is not well understood. An estimated 90% of LBP
in clinical practice is labeled “idiopathic” [1], meaning
that the mechanism is unclear. Given how little we
know about the underlying causes of LBP, it is not sur-
prising that a gold standard treatment does not cur-
rently exist. A recent survey to determine health care
utilization patterns in patients with chronic LBP, found
this population demonstrated an average of 21 visits
annually to just under three (2.7) different provider
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any medium, provided the original work is properly cited.types [3]. In conclusion, the authors state that 1) there is
a high utilization of health care for chronic LBP
patients, including a high rate of advanced imaging, nar-
cotic prescription and physical therapy; 2) most of the
tests and treatments performed did not meet the criteria
of evidence-based practice; and 3) there is an over-utili-
zation of treatment types. In addition to conventional
medical treatments such as analgesics and physical ther-
apy, LBP patients are also utilizing integrative health
care such as spinal manipulation (SM) delivered by a
doctor of chiropractic [4].
There is an increasing body of evidence suggesting
that SM provides important benefit to patients with LBP
[5,6]. Not much is known, however, about the mechan-
ism of action of these treatments. This study looks clo-
sely at the biomechanical and neural effects of SM
treatment.
In its broadest definition, SM involves the therapeutic
application of a load (i.e. force) to specific body tissues
or structures (usually vertebral joints). There are many
variations of SM in terms of their velocity, amplitude,
loading frequency, choice of lever, location and direction
of load, and treatment frequency [7,8]. Based on SM
force-time profiles, they can be divided into two broad
categories: SM with a high-velocity low-amplitude load,
or an impulse “thrust”, to body tissues (HVLA-SM) and
SM with a low-velocity variable-amplitude load (LVVA-
SM) [8-12]. LVVA-SM is often referred to as “mobiliza-
tion [13],” where HVLA-SM is referred to as “adjust-
ments [14]“ by chiropractors or “manipulation [13]“ by
other providers. HVLA-SM is typically associated with a
cavitation sound produced when the synovial joint lin-
ings are quickly separated. In LVVA-SM the loads are
applied slowly, cyclically, and the amplitude of each load
may vary.
The general theory is that the mechanism of action of
SM may be related to the impact that manipulative
forces have on tissues surrounding the low back. At the
same time, this study is considering the nature of LBP
itself. Could SM produce its beneficial effects by altering
some deficit in the spinal structure or function?
Sensorimotor Function Tests
It is well known that the spine is intrinsically dependent
on stabilizing muscle forces. Crisco and Panjabi demon-
strated in cadaveric studies that the ligamentous spine
can sustain around 88 N of compressive load before
buckling [15-19]. Therefore, neuromuscular control and
coordination are important for the normal postural sta-
bility and daily movements of the spine [15-17,20-22].
Additionally well-coordinated muscle contractions can
prevent overloading ligaments and joint capsules beyond
their physiological limits [15,16,18,19]. There is increas-
ing evidence suggesting that the dysfunction of muscle
control and coordination (i.e., sensorimotor function)
might render the spine unstable or prone to injury
[15,16,18,19,23-33].
Muscle control depends on input from length and
tension receptors in muscles as well as other proprio-
ceptors in and around spinal joints. Panjabi proposed a
hypothesis that links damage in the spinal ligaments and
discs to muscle control dysfunction seen in chronic
back pain [34]. Inaccurate feedback from proprioceptors
in ligaments, muscles and joints may prevent proper
initiation of protective muscle responses [35]. The pre-
cise nature of the proposed sensorimotor dysfunction is
still unknown. There is evidence that biomechanical
function in patients with LBP is altered, as measured by
t e s t ss u c ha sp o s t u r a ls w a y ,response to sudden impact
loads, and repositioning accuracy [36]. All of these func-
tional tests involve sensorimotor function to some
extent.
Linking SM to Sensorimotor Dysfunction
There is important work showing that forces of the
magnitude of SM loads can stimulate proprioceptors in
the joints and muscles [37,38]. The approach in this
c u r r e n ts t u d yi st ou s eS Ma sat o o lt oi n f l u e n c ep r o -
prioceptive input to spinal tissues and observe the
effects that input has on sensorimotor function. Thus,
this study may provide clues to the sensorimotor
mechanisms that underlie the observed functional defi-
cits associated with LBP, as well as the mechanism of
action of SM.
Postural Sway
The capability of a person to maintain balance in an
upright posture requires a complex integration of accu-
rate sensory input and precisely coordinated motor out-
put [39]. Sensory inputs include the vestibular system,
the visual system and the proprioceptors in muscles and
joints. Muscle activity must be simultaneously controlled
at three levels to achieve stability: spinal reflex, brain
stem balance and cognitive programming [40]. Distur-
bances to the neuromuscular system can affect the
degree of efficiency and accuracy with which posture is
maintained [41].
LBP patients have impaired postural stability com-
pared to healthy individuals [42-46]. It is hypothesized
that the reduced proprioceptive acuity derived from
muscle or joint mechanoreceptors can be a cause of
altered postural sway [47]. Another theory is that LBP
patients have impaired short-term memory that leads to
delays in processing postural control information and
increased sway [48].
Response to Sudden Impact Loads
In the flow of everyday living, people sometimes experi-
ence sudden and unanticipated forces, such as stepping
off a curb unexpectedly. An individual’s central nervous
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den loads, to the system in such a way that minimal dis-
ruption occurs to the individual’s current activities.
These sophisticated procedures include the rapid activa-
tion of muscles to oppose the sudden load and the con-
current relaxation of the corresponding antagonistic
muscles. It has been found that LBP patients respond
differently compared to healthy individuals [49-52]. It
takes their muscles longer to respond and their response
is smaller [53,54]. Several studies demonstrated that the
response of the trunk musculature is dependent on the
direction of perturbation [32,55-58]. There also appears
to be a correlation between muscle control delays in the
sudden load test and the increased postural sway in LBP
patients [59].
Repositioning Accuracy
A higher-order integration of proprioception, mostly
from mechanoreceptors in the skin, muscles and joints,
a l l o w st h eb o d yt os e n s et h ep o s i t i o no fi t sp a r t si n
space [60,61]. Mechanisms of proprioception have been
extensively studied in the limbs. Limb repositioning
tasks involve sense of position, memory of how a posi-
tion felt and motor response to return the body part to
the same position. Researchers have recently applied the
repositioning approach in studying LBP and found that
patients with chronic LBP had a decreased accuracy of
lumbo-pelvic repositioning compared to pain-free con-
trols [62-65]. Pain-free controls have a repositioning
error between 1-2 degrees, while LBP patients have an
error about twice as great, most likely due to altered
proprioceptive input from the lumbar spine
[47,62,64,66,67]. On the other hand, some studies did
not find differences in the position sense in low back
pain patients compared to healthy individuals [67-71]. It
has been suggested that impaired proprioception may
contribute to the poorer repositioning accuracy in
patients with LBP. Brumagne et al. demonstrated that
vibration of the multifidus muscle led to an increase in
the repositioning error in pain-free participants, provid-
ing evidence that muscle spindles are an important ele-
ment of lumbar proprioceptive ability [72]. Conversely,
muscle vibration in LBP patients decreased the reposi-
tioning error. This suggests that LBP and pain-free indi-
viduals are different in the way they process spindle
information [72]. Lee et al. suggested that it might be
possible to detect proprioceptive differences between
various subgroups of LBP patients using tests with a
higher motion perception threshold [65].
Aims
The primary aims of this study are to 1) determine
immediate pre to post changes in sensorimotor function
in the lumbopelvic region as measured by postural sway
following delivery of a single HVLA-SM or LVVA-SM
treatment when compared to a sham treatment consist-
ing of light effleurage and a sham mechanically assisted
adjustment and 2) to determine changes from baseline
to 2 weeks (4 treatments) of HVLA-SM or LVVA-SM
compared to a sham treatment.
Our secondary aims are to:
a) Determine immediate pre to post changes in sen-
s o r i m o t o rf u n c t i o ni nt h el u m b o p e l v i cr e g i o na s
measured by response to sudden impact loads and
lumbar repositioning accuracy error following deliv-
ery of a single HVLA-SM or LVVA-SM treatment
when compared to a sham treatment;
b) Determine pre to post changes in sensorimotor
function in the lumbopelvic region as measured by
response to sudden impact loads and lumbar reposi-
tioning accuracy error following HVLA-SM or
LVVA-SM when compared to a sham treatment fol-
lowing the delivery of 4 treatments over a 2 week
period;
c) Estimate the effects of 6 weeks (13 applications)
of HVLA-SM and LVVA-SM to the lumbopelvic
region on the 3 measures of sensorimotor function;
and
d) Explore whether changes in sensorimotor func-
tion are associated with changes in self-reported
back pain intensity, disability, or health status at 2
weeks (after 4 SM visits) and at 6 weeks (after 13
SM visits).
Methods/Design
This study was funded as a cooperative agreement with
NCCAM/NIH as part of a developmental center
(1U19AT004137) designed to collect preliminary data as
well as increase the research expertise and infrastructure
of the Palmer Center for Chiropractic Research (PCCR).
The central scientific theme of the overall developmen-
tal grant is focused on SM, LBP and mechanisms of
action of SM. The grant includes an NIH appointed
External Advisory Committee (EAC) which meets
annually to discuss the study plans and progress. The
addition of the sham / “doctor’sc h o i c e ” treatment
group was recommended by the EAC rather than the
wait-list control group proposed in the original grant
application. We also added exploratory aims to assess
the doctor and patient perception of the quality of the
SM delivery. These additional aims will be discussed in
future papers.
Overview
Approximately 219 individuals with acute, subacute or
chronic low back pain are being allocated in a 1:1:1
ratio to receive either 13 HVLA-SM treatments over 6
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treatments over 6 weeks to the lumbar and pelvic
region, or 2 weeks of a sham treatment followed by 4
weeks of full spine “doctor’sc h o i c e ” SM. Primary and
secondary outcomes are assessed at baseline visit 2
(BL2), week 2 and week 6 by assessors blinded to treat-
ment assignment.
Study population
Participants are recruited from the general population of
approximately 400,000 adults living in the Quad Cities
area (QCA) of Iowa and Illinois. The QCA is a combi-
nation of 4 cities: Davenport, IA, Bettendorf, IA; Moline,
IL; and Rock Island, IL. This study is being conducted
at the PCCR, which is located on the Palmer College of
Chiropractic (PCC) main campus in Davenport, IA.
The study protocols and the informed consent docu-
ments have been approved by the PCC’s institutional
review board (IRB) (PCC IRB# 2007M093). A Data and
Safety Monitoring Committee is also overseeing study
progress.
Inclusion and exclusion criteria
The inclusion and exclusion criteria are listed in
Table 1. Volunteers between the ages of 21 and 65 years
with acute, sub-acute or chronic low back pain who are
willing and able to sign informed consent documents
are eligible for this study. Participants must also have a
numerical pain rating scale (NRS) greater than or equal
to 4 (on a scale of 0 - 10) at either the initial computer
assisted telephone interview (CATI ) or the baseline 1
in-person interview. In addition, NRS measurements
cannot be less than 2 at any screening visit.
Exclusion criteria have been developed to screen out
patients with: safety concerns for either SM or the sen-
sorimotor testing (e.g. bleeding disorders, sensitivity to
tape, contra-indication to SM, pregnancy); unconfirmed
safety (e.g. joint replacement, pacemaker); safety concern
related to equipment weight capacity (e.g. extreme obe-
sity with weight greater than or equal to 307 pounds);
conditions that may result in intolerance to biomechani-
cal testing or treatment protocols (e.g. vascular claudica-
tion, bone and joint abnormality, inflammatory or
destructive tissue changes to the spine, osteoporosis,
Quebec Task Force classification 4, 5, 6, 8, 9, 10, 11
[73]); overall condition too poor to tolerate treatment
and biomechanical testing procedures; conditions that
may interfere with data collection (e.g. neuromuscular
diseases, peripheral neuropathies, prior spinal surgery);
conditions that might interfere with data collection and
ability to comply with study protocol (e.g. suspicion of
drug or alcohol abuse, uncontrolled hypertension,
depression according to the Beck Depression Inventory-
II
©); condition which requires surgical evaluation (e.g.
cauda equina syndrome); and other concerns which may
make it difficult to fully consent, interfere with study
compliance, or constitute a possible data confounder (e.
g. inability to read or verbally comprehend English),
indicators for diagnostic procedures beyond dipstick uri-
nalysis or x-rays, retention of legal advice for an open or
pending case related to LBP and ongoing treatment for
LBP by other health care providers.
Recruitment procedures
Initial recruitment efforts were jumpstarted through a
well-received press release to the local media when the
study began. Ongoing efforts have focused on direct
mailers to all of the QCA.
Screening and eligibility
Participants are screened fore l i g i b i l i t yu s i n gaC A T I
and if eligible scheduled for a baseline in-person screen-
ing interview and physical examination. At this appoint-
ment, baseline visit 1 (BL1), participants first complete a
HIPAA notice of privacy form, provide contact informa-
tion and sign an initial informed consent document that
allows us to use their baseline information even if they
are not enrolled in the study. They then complete ques-
tionnaires on their past medical history and provide
baseline responses to the self-report outcomes. A study
coordinator obtains participants’ height and weight and
reviews all forms for missing or incomplete data, clari-
fies any questionable entries, and enters eligibility items
into a web-based interface programmed with eligibility
checks. If a participant is eligible for further screening,
the study coordinator verbally provides an overview of
the study using a flow chart (Figure 1), explains the
forthcoming informed consent documents in detail, and
shows a video demonstrating the biomechanical and
treatment procedures used in the study.
A research clinician reviews the participant’sp a s t
medical history and initiates the clinical evaluation with
questions regarding relevant aspects of the health his-
tory. The clinician then obtains a focused history of the
participant’s low back pain and performs an eligibility
examination. To assist with diagnosis, radiographs and
urinary analysis may be ordered; if any other diagnostic
procedure is necessary to evaluate the condition, the
participant is excluded from the study and referred to
an appropriate healthcare provider. When available, and
with participant consent, health records are requested
and reviewed as part of the screening process.
Confirmation of diagnosis and determining eligibility for
the study
Following the participant examination, the clinician pre-
pares a case summary report detailing the participant’s
low back complaint, past medical history, exam findings,
diagnostic test results (if present), and diagnosis. Twice-
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Inclusion criteria Rationale Source
Age 21 y -65 y inclusive Individuals > 65 are not as likely to tolerate the biomechanical tests and
experience altered sensorimotor function. Children not considered for study
PS, BL1 Int
Acute, sub-acute or chronic LBP
matching QTF classifications 1, 2, 3 or
7
Low back pain, uncomplicated by known nerve compression, neurological signs
or prior surgery
Exam, CR
Numerical Pain Rating Scale of > 4 at
PS or BL1 &≥2 at PS, BL1, BL2
Low back pain with enough severity to demonstrate clinical improvement PS, HA1, HA2
Signed
the Informed Consent Documents
Research policy PS, BL1 Int, BL2 Int
Exclusion criteria Rationale Source
Bleeding disorders Safety concern for biomechanical testing procedures Exam, CR
Sensitivity to tape used during the
sensorimotor function tests
Safety concern for biomechanical testing procedures BL1 Int, Exam
Pregnancy or nursing Safety concern for biomechanical testing procedures PS, BL1 Int, BL2 Int
Contra-indication to SM Safety concern for treatment protocols Exam, CR
Joint Replacement Safety not confirmed for biomechanical testing PS, BL1 Int, Exam, BL2 Int
Pacemaker Safety not confirmed when used near biomechanical equipment producing
electromagnetic field
PS, BL1 Int, Exam, BL2 Int
Extreme obesity (≥ 307 lbs) Safety concern related to equipment weight capacity BL1 Int
Vascular claudication Condition can result in intolerance to biomechanical testing protocols PS, Exam, CR
Bone and joint abnormality Condition can result in intolerance to biomechanical testing or treatment
protocols
PS, Exam, CR
Inflammatory or Destructive tissue
changes to the spine
Condition can result in intolerance to biomechanical testing or treatment
protocols
Exam, CR
Osteoporosis Condition can result in intolerance to biomechanical testing or treatment
protocols
PS, Exam, CR
General poor health Overall condition is too poor to tolerate both treatment and biomechanical
testing procedures
Exam, CR
Neuromuscular Diseases Condition might interfere with data collection PS, Exam, CR
Peripheral Neuropathies Condition might interfere with data collection PS, Exam, CR
Spinal Surgery Condition might interfere with data collection PS, Exam, CR
Suspicion of drug or alcohol abuse Condition can interfere with ability to comply with study protocol and data
collection
BL1 Int, Exam, CR
Uncontrolled hypertension Condition might make it difficult to receive treatment or perform research
procedures
PS, BL1 Int, Exam
BDI-II ≥ 29 Condition can interfere with ability to comply with study protocol and data
collection
HA1
QTF 4-6 & 8-11 Condition of sufficient complicated nature to cause intolerance to
biomechanical testing procedures or data collection
Exam, CR
Cauda Equina Syndrome Requires emergency surgical evaluation Exam, CR
Inability to read or verbally
comprehend English
Difficult to ensure full consent PS, BL1 Int
Further diagnostic procedures other
than dipstick urinalysis or x-rays
Advanced diagnostic testing was unavailable Exam, CR
Retention of legal advice and open or
pending case related to LBP
May interfere with study compliance PS, BL1 Int, BL2 Int
Ongoing treatment for LBP by other
health care providers
Possible confounding data PS, BL1 Int, BL2 Int
BDI-II- Beck Depression Inventory; BL1- Baseline Visit 1; BL2- Baseline Visit 2; CR- Case Review; Exam- Determined by the examining clinician; HA1- Health
Assessment Questionnaire administered at BL1; HA2- Health Assessment Questionnaire administered at BL2; Int- Study Coordinator administered Interview; PS-
Phone CATI Screen; QTF- Quebec Task Force; SM- Spinal Manipulation
Wilder et al. Trials 2011, 12:161
http://www.trialsjournal.com/content/12/1/161
Page 5 of 15weekly case review meetings with study clinicians and
other clinic personnel are held to review findings for all
who complete the BL1. Case review meetings are
intended to: 1) facilitate consistent interpretation and
application of pre-defined eligibility criteria; 2) utilize
the combined clinical experience of multiple clinicians; 3)
ensure safety; and 4) reach an evidence-based consensus
of diagnosis for each participant.
A study coordinator prepares the case review agenda
and ensures clinic charts and other related records are
available for case review meetings. The project manager
prepares electronic presentation of the case summary
and digital imaging (if present). All electronic docu-
ments and images containing personal health informa-
tion are stored in a secure, password-protected network
file server.
Case review meetings encompass a verbal presentation
of each case by the clinician who performed the exam.
After presentation, the clinician allows panel members
to electronically review the report and ask questions.
n=73 n=73 n=73
Telephone CATI Screen
Baseline Visit 1
Preliminary Consent
Questionnaires
Interview/Video
Physical Exam
X-ray, if necessary
Case Review
Baseline Visit 2
Report of Findings
Consent to Participate
Questionnaire
Randomized to Treatment
Placebo
Sensorimotor Function Tests
Treatment 1 with Measurements
Sensorimotor Function Tests
HVLA
Sensorimotor Function Tests
Treatment 1 with Measurements
Sensorimotor Function Tests
LVVA
Sensorimotor Function Tests
Treatment 1 with Measurements
Sensorimotor Function Tests
Visit 14
Questionnaire
Sensorimotor Function Tests
Treatment 13 with 
Measurements
Sensorimotor Function Tests
Exit Interview/Discharge
Treatment Visits 2-4
  2 weeks
Visit 6
Questionnaire
Sensorimotor Function Tests
Treatment 5 with Measurements
Sensorimotor Function Tests
Treatment Visits 6-12
4 weeks
Figure 1 Participant flow chart.
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discussion points including x-ray review (if present),
compliance, safety, diagnosis and eligibility determina-
tion. An electronic manual of operating procedures is
available to reference eligibility criteria and operational
definitions as they apply to decisions made at this meet-
ing. Any recommendations for further evaluation or
referral are also determined by the panel. The group
then determines the participant’s eligibility by a final
review of the exclusion criteria and the presenting clini-
cian’s recommendation. If consensus (80% of the present
clinicians) cannot be reached, the senior clinician makes
final participant eligibility determination. Dissenting
clinical opinions are recorded. Participants excluded at
case review are contacted by the examining research
clinician who informs them that they are ineligible for
the study, reports their exam findings and provides
recommendations for follow-up with non-study
providers.
Baseline Visit 2
Treatment allocation occurs at BL2. First, a clinician
provides the participant with a verbal report of the BL1
exam findings, probing for any clinically important
change in the participant’s condition or new issues that
may impact study compliance, and answering any ques-
tions the participant has regarding their condition or
study participation. The study coordinator then meets
with the participant and answers any questions about
the study, provides an opportunity for the participant to
view the video showing the biomechanical tests and
treatment procedures again, and probes for potential
compliance issues. For eligible participants, the study
coordinator obtains and witnesses the participant’ss i g -
nature on the final informed consent document. Next,
the participant completes a questionnaire to ensure that
their NRS score is not less than 2. Finally, the study
coordinator confirms eligibility and allocates the partici-
pant to one of the three treatment groups.
Treatment Allocation
A web programmer wrote the code and a data manager
validated the code for an adaptive computer-generated
treatment allocation algorithm based on the minimiza-
tion method of Taves to allocate participants to one of
three treatment groups in a 1:1:1 allocation ratio [74].
The minimization algorithm balances group differences
over 3 baseline factors: age (21-39; 40-49; 50-65), sex
and duration of pain ( < 4 weeks; 4-12 weeks; 12 weeks-
< 6 months; 6 months- ≤ 1 year; > 1 year). The study
coordinator selects the participant unique identification
(ID) number from a dropdown list in a web-based inter-
face that produces the coded treatment group allocation.
The date and time of allocation, study personnel user ID
and group assignment are stored in the project database.
All study personnel are blinded to upcoming treatment
allocations and the biomechanical examiners remain
blinded to treatment group throughout the study. If the
web system becomes unavailable due to server failure, a
back-up treatment allocation protocol is administered
with predetermined sequentially numbered, opaque
envelopes stored in a locked cabinet in a secure area.
Subsequent allocations via the minimization algorithm
take into account all participants’ minimization
variables.
Study Treatments
HVLA-SM
HVLA-SM is performed with the participant in the lat-
eral recumbent or side-lying position. Participants attain
a side-lying position with the free hip and knee slightly
flexed and adducted while the lumbar spine and pelvis
remain roughly perpendicular to the treatment surface.
The hip and knee on the weight bearing side are
extended or very slightly flexed. The doctor stands in
front of (facing) the participant while stabilizing the free
thigh and leg with their own thigh. The participant’s
shoulder is stabilized with the doctor’s hand (stabilizing
hand) while the participant’s forearms rest across the
chest or abdomen. A high-velocity low-amplitude
manipulative thrust is applied with the doctor’so t h e r
hand (thrust or contact hand) on specific areas of the
participant’s lumbar vertebrae (mamillary process, spi-
nous process) or pelvis (posterior superior iliac spine,
ischial tuberosity, sacral ala, 1
st sacral segment, 3-4
th
sacral segment), depending on the condition, physical
findings and treatment objective. Short, controlled
movement of the doctor’s upper body, shoulder and
arm, often combined with a slight falling or “body-drop”
movement creates the motion, momentum and position
for a HVLA-SM thrust, which is delivered through the
contact hand [75]. The thrust vector varies with thera-
peutic intent and point of contact [13,76]. The doctor
does not thrust with the stabilizing hand; however, to
maintain participant stability on the treatment table,
mild counter-pressure is frequently necessary.
LVVA-SM
This technique has been used at the Palmer Center for
Chiropractic Research in previous studies [75]. In brief,
participants lie face down on a specially designed table
that allows the doctor to apply a controlled motion to
the participant’s lumbopelvic region [75,77]. The doctor
stands to one side and forms a manual contact with the
spinous process of a lumbar vertebra or on the ilium.
This contact resists the distractive force created by flex-
ing and distracting the table supporting the lower extre-
mities, which is controlled by the doctor’so t h e rh a n d .
This procedure allows for a relatively focused distractive
force under the manual vertebral contact and is com-
bined with flexion, lateral flexion or circumduction
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the lower extremities. Individual motions are deter-
mined based on characteristics of the condition and
therapeutic aim. Distraction combined with specific
movements occurs in 1-3 second intervals, in sets of 5-
20. One to three sets are typically delivered in a given
lumbar or sacroiliac area. Participants are constantly
monitored for tolerance to the amount of motion and
distractive force used during the procedure.
Sham Treatment
The sham treatment protocol, developed by the investi-
gative team, is composed of two parts. The first part
includes three light effleurage strokes, or patterns,
applied with no greater than 30 N of pressure [78].
First, the basic heart shaped stroke is performed three
times, followed by three “L” shaped strokes on each side
of the thoracic and lumbar areas. Three to four tree
strokes follow, ending with heart shaped strokes. The
procedure spans three minutes +/- 15 seconds. The sec-
ond part of the sham protocol includes the use of an
Activator IV device. An Activator IV (Activator Meth-
ods International, Ltd, Phoenix, AZ) is a handheld
spring-loaded mechanical device used to deliver a high-
velocity low-amplitude thrust and is commonly used
within the chiropractic profession. For use as a sham
treatment, a plastic or rubber guard is placed on the
Activator tip rendering it incapable of producing a
thrust. As is common in conjunction with the use of
this device, the clinician evaluates the lumbo-pelvic
region by lightly palpating the iliac crest and lower lum-
bar vertebrae and also examines the length of the parti-
cipant’s legs by gently pushing their feet together. The
clinician then places their thumb on a lumbar spinous
process and again in the sacroiliac region while simulta-
neously triggering the Activator so that a “click” is
heard. Though incapable of producing a thrust, the
device still produces the same sound.
Sensorimotor Function Tests
The sensorimotor function tests applied in this study
include postural sway, lumbar repositioning accuracy,
and response to sudden load. The participant performs
one set of these tests immediately before the treatment
and another set immediately after the treatment at the
BL2, week 2 and week 6 visits (up to six sets of sensori-
motor function tests in total). The detailed order of the
tests is illustrated in Figure 2.
Postural Sway
The ability to maintain balance in an upright standing
posture is monitored using a force plate (Model # 4060-
NC, Bertec, Inc, Columbus OH), which measures the
posture sway (i.e., the movement of the center of pres-
sure) in the anterior-posterior (X) and side-to-side (Y)
directions. The participant stands quietly on either a
solid platform (i.e., directly on the force plate) or a soft
surface (i.e., on a 10 cm thick latex foam pad) for a per-
iod of 35 seconds while blindfolded and wearing socks
without shoes. The first 30 seconds of data are recorded
at a sample rate of 1000 Hz using a Motion Monitor
data acquisition software (Innovative Sports Training,
Inc., Chicago, IL). Three postural sway outcomes are
extracted including the mean sways in the X and Y
directions away from the center and the mean planar
sway speed.
To keep the postural sway test consistent through the
study, the participant is instructed to stand in their neu-
tral stance. The biomechanical examiner then places the
participant’s feet next to one of the four preset stance
widths (24, 30, 36, or 44 cm apart between the lateral
malleoli, respectively) that is the closest to the neutral
stance. The same stance width is applied in the subse-
quent tests. However, the participant is allowed to
choose their own foot flare angles for each set of sensor-
imotor function tests. The flare angles may be different
for the solid platform and the foam platform [79,80].
Repositioning Accuracy
The lumbar repositioning accuracy, or the ability to
return to the target position (i.e., the initial lumbar cur-
vature) following a series of pelvic movements, is moni-
tored using a Polhemus electromagnetic motion capture
system (Polhemus Liberty, Polhemus, Colchester, VT).
Two Polhemus position tracking sensors are attached to
the back of the participant at the T12/L1 and S1 levels,
respectively, using double-sided adhesive foam pads.
The curvature of the lumbar spine is defined as the
inclination difference between the two sensors. The
changes in lumbar curvature are recorded using a
Motion Monitor data acquisition workstation at a sam-
pling rate of 120 Hz. To ensure the sensor placement
consistently through the study, the heights of the sen-
sors from the seating platform are recorded and applied
in the subsequent tests.
For this test, the participant sits on a rocking seat with
a 12 cm diameter cylindrical base that allows for for-
ward and backward tilting, but no sideways tilt. The feet
Solid Platform 1
Foam Platform 1
Solid Platform 2
Foam Platform 2
Practice
Neutral-Forward
Neutral-Forward*
Neutral-Backward*
Forward-Forward*
Forward-Backward*
Backward-Forward*
Backward-Backward*
Practice
Sudden load drops (6)
Normalization
* Order of positioning is randomly allocated.
Fi 2 D t il d d f th i t f ti d
Normalization & 
Response to 
Sudden Load 
Repositioning
Accuracy
Postural Sway
Repositioning
Accuracy
Response to 
Sudden Load & 
Normalization
Postural Sway
Treatment
Figure 2 Detailed order of the sensorimotor function
procedures.
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Page 8 of 15are kept flat on the floor and the chair elevation is set
so that the thighs are horizontal. The rocking motion is
centered in the pelvis and participants are instructed to
keep their head and upper trunk vertical. Participants
are blindfolded throughout the procedure to eliminate
visual cues of position. Each test starts in one of seven
motion configurations under the guidance of the biome-
chanical examiner. Participants learn the target position
by holding the posture for 5 seconds. On a cue from the
examiner, the participant moves their pelvis back and
forth in a rocking motion while keeping their head and
upper torso upright. At the end of 5 full cycles of
motion, the participant is instructed to return to their
target position and hold the posture for 5 seconds. The
3 target positions are neutral, forward, and backward sit-
ting postures. The first motion is always the neutral
starting position followed by a forward motion. Subse-
quently, there are two motion directions, either flexion
or extension within each target position. Therefore, in
addition to the first standardized motion, there are six
additional combinations of motion configurations. The
sequence of these motions is assigned by predetermined
random permuted blocks stored in the web system.
Figure 2 demonstrates one of the testing sequences.
To prevent aggravating the participant’s back pain, as
well as allowing the participant to get familiar with the
procedure, the biomechanical examiner first carefully
guides the participant through one mock repositioning
test. If an increase in pain is reported in either the back-
ward or forward direction, the corresponding target
positions are eliminated (e.g. dropping to four target
positions). The participant is also instructed to move
within their comfortable range. If the pain increases in
both directions, the whole lumbar repositioning test is
eliminated. Additionally, if there is an increase in pain
reported later in the test, the same caution is applied.
Response to Sudden Load
The response to sudden load, as characterized by the
paraspinal muscle response time and activity level fol-
lowing an unexpected pull at the upper chest, is moni-
tored using a Delsys Bagnoli EMG System (Delsys Inc,
Boston, MA) when the participant stands in the exact
same posture as that of the postural sway on the hard
surface. EMG electrodes are attached to the paraspinal
muscles bilaterally 3 cm from midline at the L3 level.
Six sudden loads with random rest periods in between
a r ea p p l i e ds u c ht h a tt h ep a r t i c i p a n tc a n n o te x p e c tt h e
incoming loads. Additionally the participant is blind-
folded and listening to white noise to block their visual
and hearing cues. Four seconds of data around the sud-
den loading events are recorded using the Motion
Monitor data acquisition software at a sampling rate of
1000 Hz. To prevent aggravating back pain, as well as
allowing the participant to get familiar to the procedure,
the biomechanical examiner first carefully guides the
participant through one mock drop test without block-
ing their vision and hearing. If an increase in pain is
reported, the procedure, as well as EMG normalization,
is discontinued for that visit.
The sudden load applied at the chest is achieved using
a light weight (1.6 kg) dropping at a preset height. The
preset drop height is calculated based on the partici-
pants’ height and weight (Drop Height (cm) = 6.582 +
0.0971 * weight (kg) + 0.0854 * height (cm)). A stiff sen-
sor bar is held tightly to the participant’sc h e s ta tt h e
level of the manubrium (just above the breasts) using
nylon straps around the back. A load cell (Model #
LC101-100, OMEGADYNE Inc., Sunbury, OH) and an
accelerometer (Model # CXL10LP3, Crossbow Technol-
ogy Inc., Milpitas, CA) are rigidly attached to the sensor
bar. A rope, passing over a pulley, connects the drop-
weight to the force transducer.
The readings at the load cell are used as a trigger to
start the data acquisition system. To keep the sudden
load test consistent through the study, the height of the
rope attachment at the chest is measured from the floor
and used in the subsequent tests. The outcome variables
to be extracted from the EMG data include the response
starting time (i.e., the delay between the rising in EMG
activity and the rising in load cell readings), the peak
response time and the peak magnitude from the right
and left paraspinal muscles, respectively.
To enable comparison between participants, an EMG
normalization procedure is performed. The participant
lays face down on a bench, with upper trunk extending
out over the front edge and supported by the elbows.
The legs are strapped to the table at the buttocks and
at the ankles. EMG is recorded when the participant
lifts their elbows off the support using their back mus-
cles and holds the posture for 5 seconds. EMG is also
recorded for 5 seconds before the lifting and for
another 5 seconds after the participant places their
elbows back to the support. If the participant reports an
increase in pain during the pre-treatment lifting phase,
the normalization procedure is discontinued. In that
case, the post-treatment normalization and sudden load
tests are also not conducted. If there is no increase in
pain before the treatment, but there is during the post-
treatment normalization lifting phase, both the post-
treatment normalization and sudden load tests are
discontinued.
Self-report outcome assessments
In addition to sensorimotor function, we are also col-
lecting data on sociodemographic characteristics, back
pain history, potential confounders, and back pain out-
come measures (Table 2). The data are collected at BL1,
BL2, week 2 and week 6.
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(RMDQ) 24 item version assesses LBP-related disabil-
ity. The RMDQ may be the most common and
respected LBP assessment instrument in LBP outcome
research [81]. Clinical improvement over time is
graded based on the analysis of serial questionnaire
scores. The minimum clinically important difference
(MCID) is estimated at 2 points [82]. The RMDQ is a
one-page questionnaire related to LBP disability with
documented reliability and validity [83] that has been
shown to be sensitive to clinical change in patients
with low back pain [84-86].
Participants are asked to rate their level of pain on an
ordinal 11-box scale (0 = no LBP; 10 = worst LBP possi-
ble) at baseline and before each treatment. The numeri-
cal pain rating scale (NRS) has excellent metric
properties, is easy to administer and score, and has
received much use in LBP research [87]. The question
captures information pertaining to pain over the past 24
hours. The MCID is a change of 2.5 points [87].
The bothersomeness of symptoms commonly associated
with LBP is measured using an existing instrument from
the LBP literature. We ask volunteers to rate the bother-
someness of their LBP are during the past week, mea-
sured on a 1 to 5 scale (1 = not at all bothersome and 5
= extremely bothersome). Bothersomeness questions are
practical and have demonstrated good internal consis-
tency, construct validity, and responsiveness to change
with time in patients with LBP and sciatica [88].
The Medical Outcomes Study 36-Item Short-Form
Health Survey version 2 (SF-36v2) is used for character-
izing the physical and mental health of our patients. It
has been used extensively in LBP research [89,90]. The
metric properties of the SF-36 as an outcome instru-
ment have been exhaustively studied with generally
excellent results [91]. For the purposes of this study we
Table 2 Baseline and follow-up assessments
Measures Baseline 1 Baseline 2 Week 2 Week 6
Baseline Information
Sociodemographic characteristics X
Back pain history X
Sensorimotor Functions Measurements
Postural Sway Pre & Post
Treatment
Pre & Post
Treatment
Pre & Post
Treatmentt
Response to Sudden Impact Loads Pre & Post
Treatment
Pre & Post
Treatment
Pre & Post
Treatment
Lumbar Repositioning Accuracy Pre & Post
Treatment
Pre & Post
Treatment
Pre & Post
Treatment
Self-report Outcome Assessments
Roland Morris Disability Questionnaire (RMDQ) X X X
Numerical Pain Rating Scale (NRS) X X X X
Quality of Life (SF-36) X X
Beck Depression Inventory (BDI-II) X X
Bothersomeness of low back pain X X X X
Low Back Pain Definition X
Fear Avoidance Beliefs Questionnaire X X
Satisfaction with back care X
Treatment-Related Information*
Adverse experiences X X X
Patient’s Quality of Treatment Perception X X X
Clinician’s Quality of Treatment Perception X X X
Assessment of Potential Confounders
Use of co-intervention: medications* X X X X
Use of co-intervention: manual therapy* X X X X
Exercise and job work load X
Smoking status X
Body Mass Index X
*-Also occurs at all treatment visits
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Page 10 of 15are interested in looking at physical function and bodily
pain. The MCID for physical function is 1 point and
bodily pain is 4 points [92].
Data collection and management
Information is collected at every stage of recruitment,
treatment allocation, and throughout treatment, so that
the patient flow can be reported according to the CON-
SORT guidelines [93]. Specifically, we collect recruit-
ment source, total number of responses per recruitment
source, potential participants’ resolution (e.g. ineligible,
do not wish to participate, allocated), the number allo-
cated to each treatment group, participant compliance
to treatment protocol, the number lost to follow-up,
and the number of participants completing the trial.
Participant self-report questionnaires are collected on
paper forms. The only identifier on a given data collec-
tion form is a unique participant ID; no other personal
identifiers are recorded on these forms. Study coordina-
tors have oversight for all paper data collection forms,
log each completed form into a form tracking interface
of the web system and submit data forms for key-entry
weekly. Paper data collection forms are stored in locked
filing cabinets. The paper forms are double key-entered
by trained data entry clerks in an MS Windows program
using range and validation checks to improve accuracy.
The project’s web system is password-protected and
uses a Microsoft SQL Server database platform to store
all data. Study personnel have unique user IDs and pass-
words restricting access from a Main Menu. All data
collected by study personnel are recorded in user-
friendly data-entry interfaces. Study coordinators assure
that clinicians and biomechanical examiners complete
paper data collection and web data-entry for the chiro-
practic research measures. The data manager creates the
data dictionaries and datasets for analysis.
Quality control procedures are utilized to ensure that
recruitment is on schedule, treatment allocation is
occurring as planned, data collection protocols are being
used accurately, data collected through the CATI and
other web interfaces are being stored correctly in the
SQL databases, sensorimotor outcome variables are
extracted from the biomechanical measurements within
2 weeks of data collection and that the data are being
transferred and retrieved properly.
Protection of human subjects and assessment of safety
This study was reviewed by the PCC’sI R B
(#2007M093). In addition, all adverse events in the trial
are summarized in routine reports submitted to the IRB
quarterly.
This trial is monitored by a Data and Safety Monitoring
Committee (DSMC) comprised of a biostatistician, medi-
cal physician, doctor of chiropractic and epidemiologists/
clinical trialists, none of whom are affiliated with Palmer.
The DSMC’s responsibilities are to ensure the overall
safety of the study participants and provide the principal
investigator with advice about the scientific and ethical
conduct of the study. The study biostatistician prepares a
study report for the DSMC including accrual plots and
other enrollment data, data collection forms processing
status, baseline characteristics of enrolled participants,
follow-up and treatment compliance, protocol violations
and all web-based reportable adverse events (see Adverse
Events) every 6 months. The DSMC meets in person
annually and by teleconference as needed.
Safety Monitoring
All participants involved in the study are monitored by
licensed doctors of chiropractic serving as research clini-
cians. Research clinicians routinely evaluate participants
for status change by probing for adverse events and per-
forming clinical evaluations at each visit throughout the
study period.
Adverse Events
We monitor safety at two levels: 1) adverse events (AE)
that are possibly, probably, or definitely related to the
practice of spinal manipulation and 2) serious adverse
events (SAE) regardless of their attribution. For this
study, we define an AE as any untoward medical occur-
rence that may present itself during the conduct of the
study and which may or may not have a causal relation-
ship with the study procedures. The Adverse Event
Grading and Reporting Protocol defines when and how
these events are reported to the DSMC and the IRB.
Clinicians assess whether an AE is: 1) mild, moderate,
severe, or serious; 2) expected (disclosed in the Consent
F o r mo rp a r to fa nu n d e r l y i n gd i s e a s e )o ru n e x p e c t e d
(more serious than expected, or not disclosed in the
Consent Form); and 3) definitely related to intervention,
probably related, possibly related, unlikely related or
unrelated.
We use the FDA definition of SAE, which is any
adverse experience occurring during treatment that
results in any of the following outcomes: death, a life-
threatening adverse experience, hospitalization or pro-
longation of existing hospitalization, a persistent or sig-
nificant disability/incapacity, or a congenital anomaly/
birth defect resulting from a pregnancy (21CFR314.80,
revised 01 April 2010). AE information is collected dur-
ing the treatment encounters and at all follow-up assess-
ments. Participants also are instructed to contact
investigators in the event of clinically important pain,
discomfort or distress that they believe may be asso-
ciated with treatment. We developed an automated
web-based system for recording and monitoring all AE’s
that are possibly, probably or definitely related to study
participation and all SAE’s. The clinical team records
Wilder et al. Trials 2011, 12:161
http://www.trialsjournal.com/content/12/1/161
Page 11 of 15unrelated and unlikely related AE’sa n dr e p o r t st h e s e
events to the IRB and DSMC quarterly. The project
managers and senior clinician are responsible for track-
ing and reporting all adverse events to the principal
investigator. The Adverse Event Grading and Reporting
Protocol determines when and how these events are
reported to the DSMC and the IRB when appropriate.
Sample size justification
We calculated power using Proc Power in SAS for a
total sample size of 219 by considering 63 patients per
group and inflating that by 15% (73 per group) to
account for drop outs. Because we anticipate no drop
outs during BL2, we considered 73 per group in the
power analyses for the immediate changes in the pre to
post treatment measurements at the first treatment, but
63 per group for the changes in the pre-treatment vari-
ables at BL2 and week 2.
We conducted power analyses for the 3 standing pos-
tural sway characteristics, mean sway away from the
center in the X and Y directions and the mean planar
sway speed. These are the primary response variables
and we estimated power using changes in similar vari-
ables collected from participants standing on a solid
force plate, described previously, in the literature and
standard deviations from our preliminary studies
[47,94]. Table 3 presents a variety of power values for
these variables.
Statistical analysis
SAS version 9.1.3 will be used for data analysis (SAS
Institute Inc., Cary, NC). Descriptive statistics of partici-
pant baseline characteristics will be presented for each
treatment group to assess their comparability as well as
the generalizability of the sample. We will use an inten-
tion-to-treat approach for all analyses. The analyses for
the primary and secondary aims are described below.
We will not impute any missing data for analysis, but
will report the amount of missing data for each variable
and the reason it is missing.
Data Analysis for Primary Aim
For each of the 3 primary response variables, the
immediate changes in the pre to post treatment mea-
surements at BL2 and the changes in the pre-treatment
variables from BL2 to week 2 will be compared across
the 3 treatment groups using analysis of covariance
(ANCOVA) adjusting for the minimization variables.
The following 2 preplanned contrasts for the 2 degrees
of freedom for treatment will be tested at 0.05: HVLA-
SM vs. sham control and LVVA-SM vs. sham control
on the adjusted means based on the ANCOVA model.
Residual plots will be used to assess the adequacy of the
model assumptions. Data transformations will be
explored when model assumptions are violated. Further
adjustments for the following baseline characteristics
will be explored to increase the precision of the esti-
mated effects: RMDQ, NRS, Quebec Task Force classifi-
cation, Beck Depression Inventory and chiropractic care
(yes/no). Adjusted group means and mean differences
between SM and control groups will be reported with
95% confidence intervals determined under the final
ANCOVA model.
Data Analysis for Secondary Aim a
The remainder of the sensorimotor variables will be
analyzed as above. However, only group means and
mean differences between SM and control groups with
95% confidence intervals will be reported, not P-values.
Data Analysis for Secondary Aim b
There is no control group at 6 weeks. Therefore,
changes between pre-sensorimotor variables collected at
BL2 and week 6 for those allocated to the SM groups
will be described separately for HVLA-SM and LVVA-
SM. Means and mean differences with 95% confidence
intervals will be reported for each variable.
Data Analysis for Secondary Aim c
Clinical outcome assessments considered include the
NRS, the RMDQ and SF-36 subscales, physical function
and bodily pain. Correlation coefficients and 95% confi-
dence intervals will be reported for changes in sensori-
motor response variables against changes in the
outcome assessments at BL2, week 2 and week 6 time
points overall and by treatment group.
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Table 3 Statistical power based on one-way ANOVA for
the 3 primary response variables testing at 0.05 level of
significance using SDs from preliminary data and the
literature
Power A Power B
Response Variable Contrasts* Contrasts*
Sway Speed Solid >99% >99%
Foam 86 80
Mean Sway X Solid 76-94 69-90
Foam 64-73 58-67
Mean Sway Y Solid 88-95 83-92
Foam 21-34 18-30
Effect sizes: Sway Speed: 4 mm/sec; Mean Sway X: 1 mm; Mean Sway Y: 0.5
mm [47,94] Power A is determined for n = 73 per group for the immediate
changes in the pre- to post-treatment measurements at the first treatment.
Power B is determined for n = 63 per group for the changes in the pre-
treatment variables at the first treatment and at week 2.
*Two 1 degree of freedom contrasts to test mean differences of HVLA-SM vs
Sham Control and LVVA-SM vs Sham Control.
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National Institutes of Health; NRS: Numerical pain rating scale; OH: Ohio;
PCC: Palmer college of Chiropractic; PCCR: Palmer Center for Chiropractic
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RMDQ: Roland-Morris Disability Questionnaire; S1: first sacral segment; SAE:
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